VERONA PHARMA P/S ADR (NASDAQ: VRNA) stock price moved downward at -2.21%. Its total market capitalization is $52452664. Its day lowest price was $4.25 and its hit its day highest price at $4.5. The stock recent volume is 6,205 shares in comparison to its average trading volume of 3659 shares. Looking at the stock’s price level on the past 52-week graph, VRNA recorded a 52-week high of $12.5 and its 52-week low of $3.65.
Verona Pharma plc (VRNA) stated that Dr. David Ebsworth, Chairman of the Company, has notified the Company that he has purchased a further 25,000 ordinary shares of 5 pence each in the Company (“Ordinary Shares”) at a total purchase price of £11,750, at a price of 47 pence per Ordinary Share. This purchase brings the total purchases made by Dr. Ebsworth during 2019 to about £125,000.
Following the purchase, Dr. Ebsworth will have an interest in the Company of 395,387 Ordinary Shares, representing 0.38% of the Company’s issued share capital.
The Healthcare sector company, Verona Pharma plc observed return of -5.56% in 5 days trading activity. The stock was at 7.59% over one-month performance. VRNA’s shares are at -3.63% for the quarter and driving a -65.08% return over the course of the past year and is now at -55.96% since this point in 2018. The average volatility for the week at 3.91% and for month was at 4.88%.